WRLD A.LIVE

02:001 report

• Gaps identified in surveillance of incidental lung nodules AuntMinnie

23:001 report

• Real-World Data Support Outpatient Tarlatamab for Community SCLC Care Targeted Oncology

22:00nothing heard

21:00nothing heard

20:00nothing heard

19:00nothing heard

18:00nothing heard

17:00nothing heard

16:00nothing heard

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:00nothing heard

08:00nothing heard

07:00nothing heard

06:00nothing heard

05:00nothing heard

04:001 report

• 10 Strategies to Increase Radon Testing and Prevent Lung Cancer Respiratory Therapy

03:00nothing heard

02:002 reports

• Blood test offers new way to track lung cancer Medical Xpress
• Beyond BMI: Unraveling the Obesity Paradox in Lung Cancer Targeted Oncology

19:002 reports

• Gamma-delta T cells destroyed SCLC in the laboratory — ScienceAlert UA.NEWS
• An Overlooked Immune Cell Killed The Deadliest Form of Lung Cancer in Lab Tests ScienceAlert

18:00nothing heard

17:00nothing heard

16:00nothing heard

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:00nothing heard

08:00nothing heard

07:00nothing heard

06:00nothing heard

05:00nothing heard

04:00nothing heard

03:00nothing heard

02:00nothing heard

01:00nothing heard

00:001 report

• Data Support Real-World Benefit of Cemiplimab in Advanced NSCLC Care CancerNetwork

23:002 reports

• Preliminary SARON results: radiotherapy extended progression-free period by 56% — News-Medical UA.NEWS
• Radiation Added to Systemic Therapy Improves PFS But Not OS for Oligometastatic NSCLC The ASCO Post

22:001 report

• Why Never-Smoking Asian Women Skip Annual Lung Cancer Screening EMJ

21:00nothing heard

20:00nothing heard

19:00nothing heard

18:00nothing heard

17:00nothing heard

16:00nothing heard

15:002 reports

• Tom Newsom-Davis։ Does Adding Radiotherapy to SACT Improve Survival in Synchronous Oligometastatic NSCLC? Oncodaily
• Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment News-Medical

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:00nothing heard

08:00nothing heard

07:004 reports

• Understanding the Stigma of Lung Cancer University of Pittsburgh Medical Center
• Why non-smokers still develop lung cancer Türkiye Today
• Jill Feldman: After 25 Years of Awareness, Are We Changing Minds About Lung Cancer? Oncodaily
• Beyond cigarettes: Uncovering the causes of lung cancer in nonsmokers The Spokesman-Review

06:001 report

• Lung Cancer Blood Test May Help Predict Treatment Outcomes Before Surgery Inside Precision Medicine

05:00nothing heard

04:00nothing heard

03:005 reports

• Liquid biopsy reliably detects early-stage lung cancer recurrence risk News-Medical
• Sucharu Prakash: Turning MRD Detection Into Actionable Clinical Decisions Oncodaily
• New Blood Test Can Find One of the Deadliest Cancers Returning—Before Scans Newsweek
• Prototype Assay Targets Early Stage Lung Cancer Detection With Circulating Biomarker Data at ESMO GenomeWeb
• MDT-BRIDGE: Early ctDNA Clearance Predicts Pathological Response and Favorable Outcomes in Stage II–III NSCLC Oncodaily

02:00nothing heard

01:00nothing heard

00:002 reports

• Metabolic vulnerability identified in small cell lung cancer Medical Xpress
• Beyond cigarettes: Uncovering the causes of lung cancer in nonsmokers The Detroit News

10:001 report

• Key Takeaways From DeLLphi-305 at ESMO 2026 Targeted Oncology

09:002 reports

• Advanced lung cancer patients benefit from radiotherapy in addition to standard treatment The Institute of Cancer Research
• Cancer breakthrough as 'added treatment' controls disease for longer Wales Online

08:00nothing heard

07:00nothing heard

06:001 report

• Tarlatamab Maintenance Combo Boosts Lung Cancer Survival Medscape

05:001 report

• ESMO Spotlight: Amgen's Imdelltra steals the show with unprecedented data in small-cell lung cancer FirstWord Pharma

04:00nothing heard

03:00nothing heard

02:00nothing heard

01:005 reports

• Aadil Najeed։ SARON Trial Shows Improved PFS and Local Disease Control With Consolidation Radiotherapy in NSCLC Oncodaily
• New trial finds 'added treatment' keeps advanced cancer under control for longer Cornwall Live
• Cancer breakthrough as 'added treatment' controls disease for longer Surrey Live
• Radiotherapy ‘could keep advanced lung cancer patients stable for longer’ LBC
• SARON: Consolidation Radiotherapy Improves PFS but Not Overall Survival in Oligometastatic NSCLC Oncodaily

00:001 report

• Lung Surgery Assessment Considers Psychological Reserve and Nutrition EMJ